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as a cut off for acceptable therapeutic intent. NTCP modeling 
of radiation induced Liver disease was also performed. 
 
Results: Non-GTV Liver mean dose ranged from 13.1 to 
17.0Gy, breaching mandatory trial constraint of <15.2Gy in 
three cases. NTCP ranged from 0.0 to 0.3 assuming an 
alpha/beta of 1.0 for normal Liver and negligible assuming 
alpha/beta of 2.0 or more. At D98%, four sets of contours did 
not achieve 65Gy BED to gold standard PTV, two sets failing 
to reach 65Gy BED at D90%.  
 
Conclusion: Significant variability exists in contours drawn by 
different centers/clinicians in the setting of pre-trial QA to 
the extent where 10% or more of the PTV receives a BED 
insufficient for local control in a proportion of cases and 
NTCP is significantly affected. Given this variability, the pre-
trial and on-trial RTTQA process is essential if the effect of 
contour variability on tumour control rates and treatment 
toxicity is to be mitigated.  
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Purpose or Objective: To use spatial features from dose 
surface maps of the duodenum to predict acute duodenal 
related toxicity in pancreatic chemoradiation. 
 
Material and Methods: Dose surface maps were produced for 
the duodenum describing the spatial surface dose 
distribution. Traditional metrics were extracted including 
mean and max dose, surface area receiving 25, 35, 45 and 55 
Gy as absolute and fraction of the surface. Spatial metrics 
extracted include the length of the duodenum which received 
less than 25, 35, 45 and 55 Gy to at least 10-90% of the 
circumference (in 10% intervals). Different thresholds for the 
length of the duodenum achieving these constraints were 
tested in order to find the best predictor of toxicity. Toxicity 
results from 19 patients from the ARCII clinical trial 
(EudraCT: 2008-006302-42) were used as a proof of concept. 
6 and 11 patients had grade (Gr) ≥3 and Gr ≥2 toxicity 
respectively.  
 
Results: The best predictors for patients with grade (Gr) ≥3 
toxicity were at higher doses of 55 Gy. While restricting the 
dose < 55 Gy to at least 10% of the circumference for at least 
10% of the length of the duodenum, or at least 20% of the 
circumference for at least 20% of the length accurately 
predicted toxicity for 74% of the patients studied, this only 
had a sensitivity of 17% and 33% respectively (specificity of 
100% and 92%). Figure 1 indicates a better predictor may be 
restricting dose < 55 Gy to at least 20% of the circumference 
for at least 70% of the length which, although only accurately 
predicts toxicity for 58% of the patients, has a sensitivity and 
specificity of 67% and 54%. It was found that the relative 
percentage of the circumference spared was a better 
predictor than absolute circumferential length spared. 
However, similarly to the spatial metrics, predictions of 
patients with at least Gr 3 toxicity was seen in the higher 
dose regions such as mean dose of 60 Gy, maximum dose to a 
pixel of 62 Gy and when 70% of the surface area receives 55 
Gy. Gr 2 toxicity could not be predicted. 
 
 
 
Conclusion: In this small sample we have shown that spatial 
features can be extracted from dose surface maps to aid 
toxicity prediction, and that high doses to the duodenum 
appear to be correlated with Gr 3 toxicity. An improved 
understanding of how these spatial features correlate to 
toxicity can improve traditional constraints on the 
duodenum. Further work is required to build a more 
complete picture of this result, and the analysis will now be 
extended to a larger patient cohort. 
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Purpose or Objective: In a previous work a model which 
simulates the radiation response of hypoxic tumors was 
developed. The task of this work is to validate the model by 
using preclinical experimental dose response data of rat 
prostate tumors for single and multiple irradiations. 
 
Material and Methods: The model is voxel-based and 
simulates the spatio-temporal behavior of tumors considering 
six radio-biological processes. Important input data are the 
oxygenation levels of each tumor subvolume at the time of 
irradiation, which are given as pre-calculated oxygen 
frequency histograms.The experimental data for validation 
include growth curves, dose response curves and TCD50s for 
1, 2 and 6-fraction (Fx) experiments. A very high α/β value of 
84.7 ± 13.8 Gy was determined.A strategy of adjustment was 
